IP Verse

Intermune competitive analysis

Latest patents of Intermune opposed by its competitors

Explore Intermune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP1940364
Jul 20, 2022Capsule Formulation Of Pirfenidone And Pharmaceutically Acceptable Excipients1
EP3053580
Jun 30, 2021Method Of Providing Pirfenidone Therapy To A Patient4
EP2653162
May 20, 2020Methods Of Administering Fluvoxamine Therapy4
EP2506850
May 13, 2020Methods Of Administering Pirfenidone Therapy6
EP2702994
Sep 21, 2016Methods Of Administering Pirfenidone Therapy2
EP2338489
Apr 27, 2016Method Of Providing Pirfenidone Therapy To A Patient3
EP2500019
Apr 6, 2016Modifying Pirfenidone Treatment For Patients With Atypical Liver Function3
EP2316453
Jan 6, 2016Methods Of Reducing Adverse Events Associated With Pirfenidone Therapy3
EP2343070
Oct 15, 2014Pirfenidone Treatment For Patients With Atypical Liver Function1

Latest PTAB cases involving Intermune

Discover the latest PTAB cases involving Intermune, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Intermune with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERMUNE - 27 - -
AERA25 - - -
ALFRED E TIEFENBACHER765 - -
SANDOZ1472619 -